Analyst Activity – Wedbush Reiterates Outperform on Miragen Therapeutics (NASDAQ:MGEN) (NASDAQ:MGEN)

ME Staff
-
0

Analyst Ratings For Miragen Therapeutics (NASDAQ:MGEN) (NASDAQ:MGEN)

Today, Wedbush reiterated its Outperform rating on Miragen Therapeutics (NASDAQ:MGEN) (NASDAQ:MGEN).

Some recent analyst ratings include

  • 3/20/2018-Wedbush Reiterated Rating of Outperform.
  • 3/22/2018-Deutsche Bank initiated coverage with a Buy rating.
  • 3/9/2018-Evercore ISI initiated coverage with a Outperform rating.
  • 2/2/2018-Cann Reiterated Rating of Buy.
  • 1/16/2018-Chardan Capital Reiterated Rating of Buy.
  • 1/12/2018-Oppenheimer initiated coverage with a Outperform rating.
  • 1/5/2018-B. Riley initiated coverage with a Buy rating.

Recent Insider Trading Activity For Miragen Therapeutics (NASDAQ:MGEN) (NASDAQ:MGEN)
Miragen Therapeutics (NASDAQ:MGEN) (NASDAQ:MGEN) has insider ownership of 44.40% and institutional ownership of 19.83%.

  • On 2/13/2018 Adam Scott Levy, Insider, bought 9,090 with an average share price of $5.50 per share and the total transaction amounting to $49,995.00.
  • On 2/13/2018 Bruce Booth, Director, bought 545,454 with an average share price of $5.50 per share and the total transaction amounting to $2,999,997.00.
  • On 12/20/2017 Thomas E. Hughes, Director, sold 12,000 with an average share price of $8.00 per share and the total transaction amounting to $96,000.00.
  • On 6/22/2017 Adam Scott Levy, Insider, bought 200 with an average share price of $7.55 per share and the total transaction amounting to $1,510.00.
  • On 3/10/2017 Kyle Lefkoff, Director, sold 5,800 with an average share price of $14.34 per share and the total transaction amounting to $83,172.00.
  • On 3/8/2017 Kyle Lefkoff, Director, sold 15,000 with an average share price of $15.40 per share and the total transaction amounting to $231,000.00.
  • On 2/28/2017 Kyle Lefkoff, Director, sold 10,258 with an average share price of $13.89 per share and the total transaction amounting to $142,483.62.

Recent Trading Activity for Miragen Therapeutics (NASDAQ:MGEN) (NASDAQ:MGEN)
Shares of Miragen Therapeutics (NASDAQ:MGEN) closed the previous trading session at 7.80 up +0.29 3.86% with shares trading hands.